MyAverix Finance
US · Healthcare
Hepion Pharmaceuticals Inc (HEPA)
Biotechnology
Hepion Pharmaceuticals Inc (HEPA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $691,408, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HEPA
Hepion Pharmaceuticals Inc (HEPA) — FAQ
What is Hepion Pharmaceuticals Inc's market cap?
Hepion Pharmaceuticals Inc (HEPA) has a reported market cap of $691,408 (data as of 2026-03-30).
What is HEPA's P/E ratio?
The price-to-earnings (P/E) ratio for Hepion Pharmaceuticals Inc (HEPA) is 18.00 (data as of 2026-03-30).
Does Hepion Pharmaceuticals Inc pay a dividend?
Dividend yield is not available in the current snapshot for Hepion Pharmaceuticals Inc (HEPA). Check the MyAverix Finance app for the latest dividend data.
What sector is Hepion Pharmaceuticals Inc in?
Hepion Pharmaceuticals Inc (HEPA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is HEPA listed on?
HEPA is listed on US.
What is Hepion Pharmaceuticals Inc's net margin?
Hepion Pharmaceuticals Inc (HEPA) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.